March 17 (Reuters) - The U.S. Food and Drug Administration declined to approve Aldeyra Therapeutics' drug for a type of eye disease, the company said on Tuesday, sending its shares plunging over 70% ...

A raw cheese producer has declined to issue a recall of two of its products after the Food and Drug Administration linked the ...

Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...

Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and potential side effects.

The FDA has issued a CRL to Aldeyra Therapeutics for its new drug application (NDA) of reproxalap to treat dry eye disease.

FDA launches new AI-powered system to track drug and vaccine side effects in real time, replacing outdated databases and saving $120 million annually.

FORT MYERS, Fla. — Noah Song’s dream of pitching in the major leagues has never been closer. The 2019 Naval Academy product had a chance to skip the minor leagues altogether when the Philadelphia ...

Ilumya has secured marketing authorisations from more than 55 health authorities worldwide.

The Food and Drug Administration on Thursday issued marketing granted orders for vaping products from Glas Inc., an independent vaping technology company based in Inglewood, California. The authorized ...